이정희 과장
#골수이식#림프구성백혈병#림프종#다발골수종
|
학력
2002 .03 ~ 2004 .02울산대학교 의학 박사
2000 .03 ~ 2002 .02울산대학교 의학 석사
1988 .03 ~ 1994 .02중앙대학교 의학 학사
2000 .03 ~ 2002 .02울산대학교 의학 석사
1988 .03 ~ 1994 .02중앙대학교 의학 학사
경력
018 .03 ~ 현재울산의대 서울아산병원 혈액내과 과장
2018 .03 ~ 현재울산의대 서울아산병원 혈액암 및 골수이식센터 소장
2008 .04 ~ 현재울산의대 서울아산병원 혈액내과 부교수, 교수
2004 .09 ~ 2008 .03울산의대 서울아산병원 혈액내과 조교수
2002 .09 ~ 2004 .08중앙대학교병원 내과 조교수
2002 .03 ~ 2002 .08중앙대학교병원 내과 임상조교수
2000 .03 ~ 2002 .02울산의대 서울아산병원 종양혈액내과 전임의
1996 .03 ~ 2000 .02울산의대 서울아산병원 내과 전공의
1994 .03 ~ 1995 .02중앙대학교병원 수련의
2018 .03 ~ 현재울산의대 서울아산병원 혈액암 및 골수이식센터 소장
2008 .04 ~ 현재울산의대 서울아산병원 혈액내과 부교수, 교수
2004 .09 ~ 2008 .03울산의대 서울아산병원 혈액내과 조교수
2002 .09 ~ 2004 .08중앙대학교병원 내과 조교수
2002 .03 ~ 2002 .08중앙대학교병원 내과 임상조교수
2000 .03 ~ 2002 .02울산의대 서울아산병원 종양혈액내과 전임의
1996 .03 ~ 2000 .02울산의대 서울아산병원 내과 전공의
1994 .03 ~ 1995 .02중앙대학교병원 수련의
논문
Prognostic impact of lymphocyte subpopulations in peripheral blood after hematopoietic stem cell transplantation for hematologic malignancies.
The detailed kinetics of cytomegalovirus-specific T cell responses after hematopoietic stem cell transplantation: 1 year follow-up data.
A Case of Primary Bone Marrow Diffuse Large B-cell Lymphoma Presenting With Fibrillar Projections and Hemophagocytic Lymphohistiocytosis.
A prospective, open-label, multicenter, observational study to evaluate the efficacy and safety of bortezomib-melphalan-prednisone as initial treatment for autologous stem cell transplantation-ineligible patients with multiple myeloma.
Allogeneic hematopoietic cell transplantation for lymphoma: baseline and posttransplant prognostic factors.
Clinical characteristics and outcomes of patients with chronic disseminated candidiasis who need adjuvant corticosteroid therapy.
Increased circulating plasma cells detected by flow cytometry predicts poor prognosis in patients with plasma cell myeloma.
Prognostic significance of recurrent additional chromosomal abnormalities in adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia.
Prospective Randomized Comparison of Idarubicin and High-Dose Daunorubicin in Induction Chemotherapy for Newly Diagnosed Acute Myeloid Leukemia.
Reduced-Intensity Conditioning with Busulfan, Fludarabine, and Antithymocyte Globulin for Hematopoietic Cell Transplantation from Unrelated or Haploidentical Family Donors in Patients with Acute Myeloid Leukemia in Remission.
Salvage therapy for acute chemorefractory leukemia by allogeneic stem cell transplantation: the Korean experience.
Alterations in the bone marrow microenvironment may elicit defective hematopoiesis: a comparison of aplastic anemia, chronic myeloid leukemia, and normal bone marrow.
Biweekly dose-dense gemcitabine-oxaliplatin and dexamethasone for relapsed/refractory aggressive non-Hodgkin lymphoma: A multicenter, single-arm, phase II trial.
Diagnostic usefulness of dynamic changes of CMV-specific T-cell responses in predicting CMV infections in HCT recipients.
Differences of cytomegalovirus diseases between kidney and hematopoietic stem cell transplant recipients during preemptive therapy.
Donor-Derived Natural Killer Cell Infusion after Human Leukocyte Antigen?Haploidentical Hematopoietic Cell Transplantation in Patients with Refractory Acute Leukemia
Dynamic prognostic value of the revised international prognostic scoring system following pretransplant hypomethylating treatment in myelodysplastic syndrome.
Evaluation of parameters obtained from the Sysmex XN-2000 for predicting the recovery of the absolute neutrophil count and platelets after hematopoietic stem cell transplantation.
Non-myeloablative conditioning for lower-risk myelodysplastic syndrome with bone marrow blasts less than 5%―a feasibility study
Prospective validation of a novel dosing scheme for intravenous busulfan in adult patients undergoing hematopoietic stem cell transplantation.
The detailed kinetics of cytomegalovirus-specific T cell responses after hematopoietic stem cell transplantation: 1 year follow-up data.
A Case of Primary Bone Marrow Diffuse Large B-cell Lymphoma Presenting With Fibrillar Projections and Hemophagocytic Lymphohistiocytosis.
A prospective, open-label, multicenter, observational study to evaluate the efficacy and safety of bortezomib-melphalan-prednisone as initial treatment for autologous stem cell transplantation-ineligible patients with multiple myeloma.
Allogeneic hematopoietic cell transplantation for lymphoma: baseline and posttransplant prognostic factors.
Clinical characteristics and outcomes of patients with chronic disseminated candidiasis who need adjuvant corticosteroid therapy.
Increased circulating plasma cells detected by flow cytometry predicts poor prognosis in patients with plasma cell myeloma.
Prognostic significance of recurrent additional chromosomal abnormalities in adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia.
Prospective Randomized Comparison of Idarubicin and High-Dose Daunorubicin in Induction Chemotherapy for Newly Diagnosed Acute Myeloid Leukemia.
Reduced-Intensity Conditioning with Busulfan, Fludarabine, and Antithymocyte Globulin for Hematopoietic Cell Transplantation from Unrelated or Haploidentical Family Donors in Patients with Acute Myeloid Leukemia in Remission.
Salvage therapy for acute chemorefractory leukemia by allogeneic stem cell transplantation: the Korean experience.
Alterations in the bone marrow microenvironment may elicit defective hematopoiesis: a comparison of aplastic anemia, chronic myeloid leukemia, and normal bone marrow.
Biweekly dose-dense gemcitabine-oxaliplatin and dexamethasone for relapsed/refractory aggressive non-Hodgkin lymphoma: A multicenter, single-arm, phase II trial.
Diagnostic usefulness of dynamic changes of CMV-specific T-cell responses in predicting CMV infections in HCT recipients.
Differences of cytomegalovirus diseases between kidney and hematopoietic stem cell transplant recipients during preemptive therapy.
Donor-Derived Natural Killer Cell Infusion after Human Leukocyte Antigen?Haploidentical Hematopoietic Cell Transplantation in Patients with Refractory Acute Leukemia
Dynamic prognostic value of the revised international prognostic scoring system following pretransplant hypomethylating treatment in myelodysplastic syndrome.
Evaluation of parameters obtained from the Sysmex XN-2000 for predicting the recovery of the absolute neutrophil count and platelets after hematopoietic stem cell transplantation.
Non-myeloablative conditioning for lower-risk myelodysplastic syndrome with bone marrow blasts less than 5%―a feasibility study
Prospective validation of a novel dosing scheme for intravenous busulfan in adult patients undergoing hematopoietic stem cell transplantation.
저서
저서 내용이 없습니다.
보도자료
보도자료 내용이 없습니다.
포스팅
Anti-leukemic effects of vosaroxin, an anti-cancer quinolone derivative, on hypomethylating agent resistant cells
Myeloid-Derived Suppressor Cells in Chronic Myelogenous Leukemia
The detailed kinetic data on cytomegalovirus (CMV)-specific T cell responses after hematopoietic stem cell transplantation: 1 year follow-up data
Inhibition of DNA methyltransferases by volasertib in HMA resistant cell lines
Treatment outcomes of myelodysplastic syndrome patients relapsing after allogeneic hematopoietic cell transplantation
Intravenous Busulfan-Based Conditioning Regimens in Allogeneic Hematopoietic Cell Transplantation for Patients with Acute Lymphoblastic Leukemia
Prognostic Impact of Mutant Allele Ratio, Not Conferred by Duplicated Fragment Length, of FMS-like
Tyrosine Kinase 3 Internal Tandem Duplication in Patients with Acute Myeloid Leukemia
Non-Myeloablative Conditioning for Lower-Risk Myelodysplastic Syndrome with Bone Marrow Blasts less than 5% ? a Feasibility Study
Frequency, Characteristics and Prognostic Significance of RUNX1 Mutations in Patients with Acute Myeloid Leukemia, Not Otherwise Specified
Identification of novel fusion genes and differentially expressed genes in acute leukemia through transcriptome analysis
Frequency, Characteristics and Prognostic Significance of RUNX1 Mutations in Patients with Acute Myeloid Leukemia, Not Otherwise Specified
Expression of JL1 Antigen in Acute Leukemia and Myelodysplastic Syndrome
Frequency, Characteristics, and Prognostic Significance of RUNX1 Mutations in Patients with Acute Myeloid Leukemia, Not Otherwise Specified
Bone Marrow Histopathology with Gene Mutational Correlation in Patients with Essential Thrombocythemia and Primary Myelofibrosis
Predictive Value of Post-transplant Molecular Minimal Residual Disease Monitoring Versus Pretreatment
Risk Factors in Patients with Favorable Risk Acute Myeloid Leukemia Following Hematopoietic Stem Cell Transplantation
Two cases of anterior mediastinal mass supported with extracorporeal membrane oxygenation
A Case of Refractory Anemia with Ring Sideroblasts associated with marked Thrombocytosis
A Case of Simultaneous Bone Marrow involvement of Peripheral T cell Lymphoma, NOS in liver and Diffuse Large B cell Lymphoma in stomach
Changes of Hematopoietic Microenvironment and Lymphocytes in Hematopoietic Stem Cell
Transplantation of Acute Lymphoblastic Leukemia: Comparison between Relapse and Non-relapse groups
Simplified Immunophenotyping Panel for Multiple Myeloma to differentiate neoplastic myeloma cells from reactive plasma cells
Myeloid-Derived Suppressor Cells in Chronic Myelogenous Leukemia
The detailed kinetic data on cytomegalovirus (CMV)-specific T cell responses after hematopoietic stem cell transplantation: 1 year follow-up data
Inhibition of DNA methyltransferases by volasertib in HMA resistant cell lines
Treatment outcomes of myelodysplastic syndrome patients relapsing after allogeneic hematopoietic cell transplantation
Intravenous Busulfan-Based Conditioning Regimens in Allogeneic Hematopoietic Cell Transplantation for Patients with Acute Lymphoblastic Leukemia
Prognostic Impact of Mutant Allele Ratio, Not Conferred by Duplicated Fragment Length, of FMS-like
Tyrosine Kinase 3 Internal Tandem Duplication in Patients with Acute Myeloid Leukemia
Non-Myeloablative Conditioning for Lower-Risk Myelodysplastic Syndrome with Bone Marrow Blasts less than 5% ? a Feasibility Study
Frequency, Characteristics and Prognostic Significance of RUNX1 Mutations in Patients with Acute Myeloid Leukemia, Not Otherwise Specified
Identification of novel fusion genes and differentially expressed genes in acute leukemia through transcriptome analysis
Frequency, Characteristics and Prognostic Significance of RUNX1 Mutations in Patients with Acute Myeloid Leukemia, Not Otherwise Specified
Expression of JL1 Antigen in Acute Leukemia and Myelodysplastic Syndrome
Frequency, Characteristics, and Prognostic Significance of RUNX1 Mutations in Patients with Acute Myeloid Leukemia, Not Otherwise Specified
Bone Marrow Histopathology with Gene Mutational Correlation in Patients with Essential Thrombocythemia and Primary Myelofibrosis
Predictive Value of Post-transplant Molecular Minimal Residual Disease Monitoring Versus Pretreatment
Risk Factors in Patients with Favorable Risk Acute Myeloid Leukemia Following Hematopoietic Stem Cell Transplantation
Two cases of anterior mediastinal mass supported with extracorporeal membrane oxygenation
A Case of Refractory Anemia with Ring Sideroblasts associated with marked Thrombocytosis
A Case of Simultaneous Bone Marrow involvement of Peripheral T cell Lymphoma, NOS in liver and Diffuse Large B cell Lymphoma in stomach
Changes of Hematopoietic Microenvironment and Lymphocytes in Hematopoietic Stem Cell
Transplantation of Acute Lymphoblastic Leukemia: Comparison between Relapse and Non-relapse groups
Simplified Immunophenotyping Panel for Multiple Myeloma to differentiate neoplastic myeloma cells from reactive plasma cells
영상자료
영상자료 내용이 없습니다.
발표자료
골수형성이상증후군 골수생검에서 면역조직화학염색으로 시행한 CD34 및 p53 발현양상과 예후와의 연관성
CD34 및 p53 면역조직화학염색을 이용한 저세포성 골수형성이상증후군과 재생불량성빈혈의 감별진단
HLA-HAPLOIDENTICAL FAMILIAL DONOR HEMATOPOIETIC CELL TRANSPLANTATION WITHOUT EX VIVO- T CELL DEPLETION AFTER REDUCED-INTENSITY CONDITIONING OF BUSULFAN, FLUDARABINE, AND ANTI-THYMOCYTE GLOBULIN
Alemtuzumab treatment for aplastic anemia (AA) and low-risk myelodysplastic syndrome (MDS): preliminary results
C3435T polymorphism of MDR1 gene is not associated with p-glycoprotein function of leukemic blasts and clinical outcomes in patients with acute myeloid leukemia
Preliminary results of a prospective multicenter phase III trial comparing high-dose and standard-dose daunorubicin for induction of complete remission (CR) in acute myeloid leukemia (AML)
급성림프아구성백혈병에서 형태학적 관해 후 유세포분석을 이용한 미세잔존백혈병의 예후인자로서의 의의
Prognostic significance of FLT3 mutation in paired initial and relapse marrow samples of acute myeloid leukemia
Detection for FLT3 D835 and internal tandem duplication (ITD) mutation in adult acute non T-cell lymphoblastic leukemia
급성 림프구성 백혈병에서 형태학적 관해 후 유세포분석을 이용한 미세잔존백혈병의 예후인자로서의 의의
CD34 및 p53 면역조직화학염색을 이용한 저세포성 골수형성이상증후군과 재생불량성빈혈의 감별진단
HLA-HAPLOIDENTICAL FAMILIAL DONOR HEMATOPOIETIC CELL TRANSPLANTATION WITHOUT EX VIVO- T CELL DEPLETION AFTER REDUCED-INTENSITY CONDITIONING OF BUSULFAN, FLUDARABINE, AND ANTI-THYMOCYTE GLOBULIN
Alemtuzumab treatment for aplastic anemia (AA) and low-risk myelodysplastic syndrome (MDS): preliminary results
C3435T polymorphism of MDR1 gene is not associated with p-glycoprotein function of leukemic blasts and clinical outcomes in patients with acute myeloid leukemia
Preliminary results of a prospective multicenter phase III trial comparing high-dose and standard-dose daunorubicin for induction of complete remission (CR) in acute myeloid leukemia (AML)
급성림프아구성백혈병에서 형태학적 관해 후 유세포분석을 이용한 미세잔존백혈병의 예후인자로서의 의의
Prognostic significance of FLT3 mutation in paired initial and relapse marrow samples of acute myeloid leukemia
Detection for FLT3 D835 and internal tandem duplication (ITD) mutation in adult acute non T-cell lymphoblastic leukemia
급성 림프구성 백혈병에서 형태학적 관해 후 유세포분석을 이용한 미세잔존백혈병의 예후인자로서의 의의